Skip to main content
logo
USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
14.87
+0.15 (1.02%)
At close: Nov 3, 2026, 4:00 PM EST
12.98
-1.89 (-12.71%)
Pre-market: Nov 4, 2026, 4:35 AM EST

USANA Health Sciences Cash Flow Statement

Millions USD. Fiscal year is Feb - Jan.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
10.7642.0363.7969.35116.51
Depreciation & Amortization
39.722.2320.421.4122.19
Loss (Gain) From Sale of Assets
-2.0900.010.140.06
Asset Writedown & Restructuring Costs
6.97----
Stock-Based Compensation
13.8314.5614.613.3314.3
Other Operating Activities
-3.74-4.82-0.15-1.11.23
Change in Inventory
-34.69-2.122.3515.8-14.7
Change in Accounts Payable
5.2-1.27-0.43-2.66-4.57
Change in Other Net Operating Assets
-13.6-9.62-29.92-12.37-13.79
Operating Cash Flow
22.3560.9970.64103.9121.23
Operating Cash Flow Growth
-63.36%-13.66%-32.01%-14.29%-24.42%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-13.82-10.07-14.49-10.4-12.76
Sale of Property, Plant & Equipment
3.910.060.020.010.02
Cash Acquisitions
--203.34--6.53-
Other Investing Activities
-0.210.262.54.56-1.44
Investing Cash Flow
-10.13-213.09-11.98-12.37-14.19

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Short-Term Debt Issued
17.623.691.5411-
Total Debt Issued
17.623.691.5411-
Short-Term Debt Repaid
-26.6-1.47-0.75-11-
Total Debt Repaid
-26.6-1.47-0.75-11-
Net Debt Issued (Repaid)
-922.220.79--
Repurchase of Common Stock
-29.85-12.67-14.69-30.09-181.41
Other Financing Activities
-1.75--0.34--
Financing Cash Flow
-40.69.55-14.24-30.09-181.41

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
5.11-6.19-2.5-13.782.09
Net Cash Flow
-23.27-148.7441.9347.67-72.28

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
8.5350.9256.1593.5108.46
Free Cash Flow Growth
-83.26%-9.31%-39.95%-13.79%-25.36%
Free Cash Flow Margin
0.92%5.96%6.10%9.36%9.14%
Free Cash Flow Per Share
0.462.662.904.845.33
Levered Free Cash Flow
36.8563.161.35104.19112.81
Unlevered Free Cash Flow
37.3763.2861.51104.31112.84

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Cash Interest Paid
0.660.080.070.050.01
Cash Income Tax Paid
37.1840.442.3345.7559.33
Change in Working Capital
-43.08-13-280.77-33.06
SEC Filings: 10-K · 10-Q